Join
Live feed
·
PRReleasevia Quantisnow
Boundless Bio Inc. logo

Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway

ByQuantisnow·Wall Street's wire, on your screen.
BOLD· Boundless Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BOLD (Boundless Bio Inc.) and more on Quantisnow.